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Summary. The lectin from Helix pomatia, the Roman 
snail (HPA), recognises terminal alpha N-acetyl- 
galactosamine residues. A large number of lectin histo- 
chemical studies have demonstrated that expression of 
HPA-binding glycoproteins by cancer cells to be a 
marker of metastatic competence and poor prognosis in a 
range of common human adenocarcinomas, including 
those of breast, stomach, ovary, oesophagus, colorectum, 
thyroid and prostate. Around 80% of metastases arising 
from primary breast cancer are predictably HPA 
positive, but, intriguingly, around 20% do not express 
HPA binding glycoproteins reflecting the complexity of 
metastatic mechanisms and the further disruptions in 
cellular glycosylation that attend tumour progression. 
HPA binding is not an independent prognostic factor, but 
is strongly associated with the presence of metastases in 
local lymph nodes. It does appear to be independent of 
other clinical features of prognostic importance such as 
tumour size, histological grade, S-phase fraction, ploidy, 
and there is little convincing evidence of any association 
with oncogene expression or hormone receptor 
positivity. The  precise nature of the metastasis- 
associated HPA binding partner(s) is a question of some 
interest, but thus far remains unclear. HPA will 
recognise, for example, the Tn epitope and blood group 
A antigen, but its prognostic significance appears to be 
through recognition of a much broader and hetero- 
geneous array of N-galactosaminylated glycoproteins. 
Their synthesis appears to be mediated through 
alteration in expression or activity of one or more of the 
enzymes of glycosylation. The most likely putative roles 
of HPA-binding ligands in the metastatic cascade may be 
enhancement of invasive capacity, or interaction with an 
as yet unidentified lectin-like receptor facilitating 
adhesion processes. The  prognostic information 
provided by HPA lectin histochemistry may be used 
clinically to inform the physician and aid treatment 
decisions; far more interesting is the challenge of further 
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understanding the precise nature of the HPA-binding 
ligands, and defining their role in the complex 
mechanisms of metastasis. 
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Introduction 
It has been more than a decade since we first 
reported that expression of HPA binding glycans by 
breast cancer cel ls  is associated with aggressive 
biological behaviour, metastasis, and poor long term 
patient prognosis (Leathem and Brooks, 1987a). Since 
that time, a number of studies from groups world-wide 
have confirmed the prognostic significance of HPA 
binding in breast cancer (Fenlon et al., 1987; Fukutomi 
et al., 1989, 1991; Alam et al., 1990; Noguchi et al., 
1993a,b, 1994a; Thomas et al., 1993). Expression of 
HPA binding glycoproteins by cells of the primary 
tumour appears to be a powerful marker of poor patient 
prognosis. For example, in a 24 year retrospective study 
of 373 breast cancer patients, of which 293 (79%) had 
HPA positive tumours and 80 (21%) had HPA negative 
tumours, highly significant differences in survival were 
observed between the two groups. At 5 years after 
diagnosis, approximately 85% of patients with HPA 
negative tumours were alive compared with only 
approximately 55% of patients with HPA positive 
tumours; at 10 years after diagnosis, approximately 65% 
of patients with HPA negative tumours were alive 
compared with approximately 30% of patients with HPA 
positive tumours (p<0.00001) (Brooks and Leathem, 
1991). 
The lectin extracted from the albumin gland of Helix 
pomatia, the Roman or edible snail, has a nominal 
monosaccharide binding specificity for a-glycosidically 
linked N-acetylgalactosamine (GalNAc). Oligo- 
saccharides containing GalNAc a 1  -3 GalNAc non- 
reducing termini appear to be the best inhibitors of the 
agglutinin yet tested (Baker et al., 1983). The binding 
preference of the lectin can be summarised as follows: 















